Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 23 clinical trials
Featured trial
Are you 65 or over with high cholesterol?

Are you 65 or over with high cholesterol?

  • 198 views
  • 08 Nov, 2020
  • 1 location
Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial

for lowering LDL-cholesterol focused on statins, therefore doubling of previously described dose of statin would be common way in patients with inadequate LDL-cholesterol levels. Adding ezetimibe will

  • 0 views
  • 21 Jun, 2021
  • 1 location
Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease

cholesterol absorption inhibitors ezetimibe and PCSK9 inhibitor, large-scale clinical studies have been conducted to lower LDL cholesterol using these drugs. In this study, as in the statin study

cardiovascular disease
hmg-coa reductase inhibitors
rosuvastatin
LDL Cholesterol
ezetimibe
  • 0 views
  • 12 Dec, 2021
  • 2 locations
Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant Recipients (ACAV)

, nicotinic acid or ezetimibe is not recommended in post-transplant scenario. Inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9) increase availability has emerged as a novel drug tool for LDL

  • 1 views
  • 10 May, 2022
  • 1 location
RAndomized Comparison of Efficacy and Safety of Lipid-lowerING With Statin Monotherapy Versus Statin/Ezetimibe Combination for High-risk Cardiovascular Diseases (RACING Trial)

in patients with inadequate lowering LDL-cholesterol level. Additive ezetimibe will also an alternative strategy not only to lower LDL-cholesterol level and also to reduce the need of dosage of high

cardiovascular disease
infarct
arteriopathy
ezetimibe
acute coronary syndrome
  • 13 views
  • 25 Feb, 2022
  • 1 location
Ezetimibe Utilization Early After Acute Myocardial Infarction "EzAMI Trial"

Rationale Patients with acute coronary syndromes are at an increased risk for recurrent adverse coronary events, particularly during the early period following their initial presentation. Early (in-hospital) initiation of high-intensity statins reduces the risk of recurrent events and is therefore recommended by the best current practice guidelines.(1,2) However, the delayed …

combination therapy
hmg-coa reductase inhibitors
statin therapy
evolocumab
myocardial infarction
  • 0 views
  • 06 Aug, 2021
  • 1 location
Usual Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin on Coronary Atherosclerotic Plaque

The aim of this prospective, open-label, randomized, single center study is to compare the effect of usual dose rosuvastatin plus ezetimibe and high-dose rosuvastatin on modifying

intravascular ultrasound
rosuvastatin
stenosis
heart disease
ezetimibe
  • 10 views
  • 18 Nov, 2021
  • 1 location
Compare the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy Versus Rosuvastatin Monotherapy in Korean Patients With Left Ventricular Diastolic Dysfunction and Hyperlipidemia

do not qualify as exclusion criteria should be enrolled in the study and randomly assigned in a 1: 1 dose of rosuvastatin/ezetimibe 10/10mg once daily or rosuvastatin 20 mg once daily. Patients who

  • 0 views
  • 03 Feb, 2021
  • 1 location
CHOlesterol Lowering and Residual Risk in Type 2 Diabetes (CHORD)

inhibitor and statin or ezetimibe) for 1 month with the same risk factors being measured following cholesterol reduction. This study will help understand why individuals with type 2 diabetes are at higher

stroke
heart disease
Accepts healthy volunteers
hmg-coa reductase inhibitors
  • 0 views
  • 21 Mar, 2022
  • 1 location
Cholesterol Disruption in Combination With FOLFIRINOX in Patients With Metastatic Pancreatic Adenocarcinoma

cholesterol. The combination of atorvastatin, ezetimibe and Repatha, which are 3 cholesterol-lowering drugs used in combination, is safe, well tolerated and efficient over years of treatment. Recent reports

cancer
breast ductal carcinoma
pancreatic ductal adenocarcinoma
metastatic pancreatic adenocarcinoma
adenocarcinoma
  • 0 views
  • 27 Nov, 2021
  • 1 location